Index of reports
> Cases with Drug Ineffective (35)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal Consta (Risperidone) where reactions include drug ineffective. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 35 Next >>
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from Norway on 2012-07-20
Patient: male
Reactions: Hospitalisation, Drug Ineffective, Coma, Feeling Abnormal, Verbal Abuse
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Dosage: since some years
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Dosage: dose decreased about 2 years before this report
Risperdal Consta
Dosage: dose decreased about 6 months before this report
Other drugs received by patient: Abilify
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Risperdal Consta side effects in 36 year old male
Reported by a physician from Switzerland on 2012-07-02
Patient: 36 year old male
Reactions: Drug Ineffective, Psoriasis
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in 39 year old female
Reported by a consumer/non-health professional from Turkey on 2012-07-02
Patient: 39 year old female
Reactions: Chest Discomfort, Angina Pectoris, Drug Ineffective
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in male
Reported by a physician from Philippines on 2012-06-26
Patient: male
Reactions: Drug Ineffective, Hypoglycaemia, Urinary Incontinence, Intentional Drug Misuse, Throat Tightness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
End date: 2012-06-11
Invega Sustenna
Indication: Schizophrenia
Start date: 2012-06-11
Risperdal Consta
Indication: Schizophrenia
End date: 2012-06-11
Glipizide
Dosage: 4 tablets per meal
Indication: Product Used FOR Unknown Indication
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-06-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-05-31
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Risperdal Consta side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-29
Patient: female
Reactions: Drug Ineffective, Encephalitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Risperdal Consta
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Possible Risperdal Consta side effects in female
Reported by a physician from Norway on 2012-05-08
Patient: female
Reactions: Restlessness, Drug Ineffective, Parkinsonism, Migraine With Aura, Blood Prolactin Increased, Visual Impairment, Blood Cholesterol Increased, Tardive Dyskinesia, Tension, Latent Autoimmune Diabetes in Adults
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisordinol
Indication: Schizophrenia, Paranoid Type
Start date: 1994-01-01
Trilafon
Dosage: 108 mg/ml
Trilafon
Indication: Schizophrenia, Paranoid Type
Seroquel
Indication: Schizophrenia, Paranoid Type
Start date: 2003-07-01
Risperdal
Indication: Schizophrenia, Paranoid Type
Trilafon
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 1993-01-01
End date: 1994-01-01
Risperdal Consta
Indication: Schizophrenia, Paranoid Type
Start date: 2003-05-30
End date: 2003-07-21
Risperdal
Start date: 2003-05-30
End date: 2003-07-21
Possible Risperdal Consta side effects in male
Reported by a physician from China on 2012-05-02
Patient: male
Reactions: Drug Ineffective, Suspiciousness, Abnormal Behaviour, Delusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Risperdal Consta
Start date: 2011-03-26
End date: 2011-03-31
Risperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Schizophrenia
Sertraline Hydrochloride
Administration route: Oral
Indication: Depression
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-23
Patient: male
Reactions: Cataract, Drug Ineffective, Adverse Drug Reaction, Squamous Cell Carcinoma of Skin
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Dosage: began 15 years ago on an unspecified date in 1997
Chlorpromazine
Indication: Hallucination
Risperdal
Start date: 2011-01-01
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2005-01-01
End date: 2011-01-01
Risperdal
Dosage: began 15 years ago on an unspecified date in 1997
Indication: Hallucination
Risperdal Consta
Chlorpromazine
Indication: Schizophrenia
Risperdal
Start date: 2011-01-01
Risperdal
Indication: Schizophrenia
Start date: 2011-01-01
Risperdal
Dosage: began 15 years ago on an unspecified date in 1997
Indication: Autism
Other drugs received by patient: Levothyroxine Sodium; Depakote; Diphenhydramine HCL; Fluvoxamine Maleate; Paxil; Benztropine Mesylate; Benztropine Mesylate; Lorazepam
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03
Patient: male
Reactions: Negative Thoughts, Drug Ineffective, Insomnia, Gastrooesophageal Reflux Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Indication: Schizoaffective Disorder
Start date: 2012-02-01
End date: 2012-02-01
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2012-03-01
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Depakote; Depakote; Cogentin
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-23
Patient: male, weighing 95.3 kg (209.6 pounds)
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Risperdal Consta side effects in
Reported by a pharmacist from United States on 2012-03-14
Patient:
Reactions: Drug Ineffective, Condition Aggravated
Drug(s) suspected as cause:
Risperdal Consta
Invega Sustenna
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Possible Risperdal Consta side effects in 40 year old male
Reported by a consumer/non-health professional from United Kingdom on 2012-02-27
Patient: 40 year old male
Reactions: Drug Ineffective, Suicide Attempt, Pulmonary Embolism, Suicidal Ideation
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from France on 2012-02-07
Patient: female
Reactions: Incoherent, Road Traffic Accident, Drug Ineffective, Feeling Abnormal
Drug(s) suspected as cause:
Risperdal Consta
Other drugs received by patient: Tegretol; Zyprexa; Haldol; Risperdal; Zolpidem; Tranxene; TOP MAG; Risperdal; Risperdal
Possible Risperdal Consta side effects in 21 year old male
Reported by a physician from France on 2012-01-27
Patient: 21 year old male
Reactions: Drug Ineffective, Suicidal Ideation, Delusion
Drug(s) suspected as cause:
Risperdal Consta
Other drugs received by patient: Lexomil; Valium; Loxapine HCL; Imovane
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from France on 2012-01-27
Patient: female
Reactions: Incoherent, Road Traffic Accident, Drug Ineffective, Feeling Abnormal
Drug(s) suspected as cause:
Risperdal Consta
Other drugs received by patient: Risperdal; Haldol; Zolpidem; Zyprexa; Tegretol; Risperdal; Tranxene; Risperdal; TOP MAG
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-25
Patient: female, weighing 74.8 kg (164.6 pounds)
Reactions: Agitation, Drug Ineffective, Restlessness, Dyskinesia, Hyperhidrosis, Constipation, Myalgia, Speech Disorder, Overdose, Incontinence, Insomnia, Sedation, Skin Odour Abnormal, Musculoskeletal Stiffness, Gait Disturbance
Drug(s) suspected as cause:
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-12-18
End date: 2011-12-30
Risperdal
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-18
End date: 2012-01-19
Invega Sustenna
Indication: Schizophrenia
Start date: 2012-01-18
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-13
Patient: female
Reactions: Weight Decreased, Refusal of Treatment by Patient, Contusion, Drug Ineffective, Insomnia, Nervous System Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Risperdal Consta
Start date: 2011-05-01
Risperdal Consta
Indication: Sleep Disorder Therapy
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-05-01
Other drugs received by patient: Klonopin; Remeron; Klonopin
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-06
Patient: male, weighing 79.4 kg (174.6 pounds)
Reactions: Restlessness, Nonspecific Reaction, Drug Ineffective, Pain, Rhinorrhoea, Hyperhidrosis, Insomnia, Anger, Staring
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Indication: Autism
Start date: 2010-01-01
End date: 2011-12-28
Risperdal
Dosage: 1 mg in am and 1 mg in pm
Administration route: Oral
Start date: 2002-01-01
End date: 2003-01-01
Risperdal
Administration route: Oral
Start date: 2003-01-01
End date: 2011-12-28
Risperdal Consta
Start date: 2011-12-28
Risperdal
Administration route: Oral
Indication: Autism
Start date: 2003-01-01
End date: 2011-12-28
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2011-12-28
Risperdal Consta
Indication: Schizophrenia
Start date: 2010-01-01
End date: 2011-12-28
Risperdal
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2003-01-01
End date: 2011-12-28
Risperdal Consta
Start date: 2011-12-28
Risperdal
Dosage: 1 mg in am and 1 mg in pm
Administration route: Oral
Indication: Schizophrenia
Start date: 2002-01-01
End date: 2003-01-01
Risperdal
Dosage: 1 mg in am and 1 mg in pm
Administration route: Oral
Start date: 2002-01-01
End date: 2003-01-01
Risperdal
Dosage: 1 mg in am and 1 mg in pm
Administration route: Oral
Start date: 2002-01-01
End date: 2003-01-01
Risperdal Consta
Start date: 2011-12-28
Risperdal Consta
Indication: Mental Retardation
Start date: 2010-01-01
End date: 2011-12-28
Risperdal Consta
Start date: 2011-12-28
Risperdal
Administration route: Oral
Indication: Mental Retardation
Start date: 2003-01-01
End date: 2011-12-28
Other drugs received by patient: Sipraktin; Sipraktin
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-03
Patient: male, weighing 79.4 kg (174.6 pounds)
Reactions: Psychotic Disorder, Drug Ineffective, Schizoaffective Disorder, Self Injurious Behaviour
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
End date: 2010-01-01
Haldol
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-01-01
Risperdal Consta
Start date: 2011-09-01
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2010-01-01
End date: 2011-03-01
Risperdal Consta
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-01-01
Risperdal Consta
Start date: 2011-03-01
End date: 2011-09-01
Other drugs received by patient: Risperdal; Buspar; Clozaril; Clozaril; Buspar; Risperdal
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2011-12-09
Patient: male, weighing 77.1 kg (169.6 pounds)
Reactions: Drug Ineffective, Aggression, Delusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2011-01-01
End date: 2011-01-01
Invega Sustenna
Indication: Schizoaffective Disorder
Start date: 2010-01-01
End date: 2011-01-01
Risperdal Consta
Start date: 2006-01-01
End date: 2010-01-01
Risperdal
Indication: Schizoaffective Disorder
Risperdal Consta
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-09-01
Risperdal
Risperdal Consta
Start date: 2011-09-01
Other drugs received by patient: Clozapine; Buspar
Possible Risperdal Consta side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-07
Patient: male
Reactions: Drug Ineffective
Drug(s) suspected as cause:
Invega Sustenna
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Possible Risperdal Consta side effects in
Reported by a consumer/non-health professional from Canada on 2011-12-06
Patient:
Reactions: Drug Ineffective, Blood Prolactin Decreased
Drug(s) suspected as cause:
Risperdal Consta
Page 1 Next >>
|